#USA #KMM Group #Hatboro #RS2 Healthcare #J. Mark King

KMM Group Secures Strategic Investment from RS2 Healthcare Partners

KMM Group, a leader in precision manufacturing for the medical device sector, has successfully secured a significant investment from RS2 Healthcare Partners, a well-regarded private equity firm based in Boston. The announcement made on July 27, 2026, marks a turning point for KMM Group, setting the stage for its ambitious growth trajectory within highly demanding markets.

KMM Group is recognized for its expertise in creating complex, tight-tolerance components critical for medical devices and other sectors that require uncompromising quality and precision. This new infusion of capital from RS2 Healthcare Partners comes with the aim of enhancing the company’s capabilities and ensuring it remains at the forefront of innovation in medical technology manufacturing.

In tandem with the investment, KMM Group has also announced a restructuring of its leadership team. J. Mark King, a seasoned veteran in the medical device industry with over 30 years of experience, has taken the helm as the President and Chief Executive Officer. Previously, Mr. King led Tegra Medical, another significant player in the medical contract manufacturing space, which was formerly part of RS2’s portfolio.

Co-founder John Shegda transitions into the role of Chief Technology Officer, where he will focus on steering KMM’s engineering and technological strategies. Meanwhile, fellow co-founder Eric Wilhelm assumes the role of Executive Vice President, managing business transformation and operational capabilities. This strategic leadership transition aims to ensure continuity for stakeholders while effectively positioning KMM Group for sustained growth and excellence in manufacturing practices.

J. Mark King expressed his enthusiasm, noting, “KMM has earned customers' trust by tackling complex manufacturing challenges that many others find insurmountable. With this investment from RS2, I’m excited to work alongside the experienced teams to expand our capabilities and solidify our position as a premier contract manufacturer in the medtech landscape.” King’s previous roles include positions at industry giants such as Baxter Healthcare and Johnson & Johnson, further underscoring his depth of knowledge and experience in the sector.

John Shegda emphasized the necessity for KMM to remain ahead of the evolving manufacturing landscape, “Our focus is to advance our manufacturing technology and enhance our engineering capabilities. This investment will help us partner with clients in bringing the next generation of life-saving medical products to market.”

Eric Wilhelm added, “As our company grows, we aim to strengthen our operations while maintaining the culture and commitment to excellence that has defined us.”

Craig Stern, Co-Managing Partner at RS2 Healthcare Partners, praised KMM Group's solid reputation and specialized capabilities. With RS2’s deep experience in scaling founder-owned businesses, the partnership seems poised for mutual benefits as they navigate the complexities of the medical manufacturing environment together.

The combination of strategic investment and experienced leadership signals a bright future for KMM Group as it aims to be a leader in meeting the evolving demands of the medical device industry. With a commitment to quality and innovation as fundamental pillars, KMM is uniquely positioned to continue its path toward operational excellence and market leadership.

• ---

About KMM Group

KMM Group specializes in high-precision contract manufacturing, addressing the complex engineering needs of the medical device sector. Their technical prowess and scalable production capabilities are set to transform challenges into breakthroughs.

About RS2 Healthcare Partners

Founded in 1989, RS2 Healthcare Partners is focused on private equity investments in healthcare, particularly within the lower middle market. Their collaborative approach aims to empower management teams through strategic support and sector expertise.